MN Services Vermogensbeheer’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.55M | Sell |
112,077
-41,600
| -27% | -$2.77M | 0.06% | 282 |
|
|
2026
Q1 | $9.65M | Hold |
153,677
| – | – | 0.06% | 260 |
|
|
2025
Q4 | $10.2M | Buy |
153,677
+7,077
| +5% | +$458K | 0.06% | 258 |
|
|
2025
Q3 | $9.87M | Hold |
146,600
| – | – | 0.06% | 261 |
|
|
2025
Q2 | $12.8M | Buy |
146,600
+6,800
| +5% | +$533K | 0.09% | 224 |
|
|
2025
Q1 | $9.55M | Sell |
139,800
-10,800
| -7% | -$881K | 0.07% | 246 |
|
|
2024
Q4 | $11.7M | Buy |
150,600
+2,500
| +2% | +$185K | 0.08% | 234 |
|
|
2024
Q3 | $9.93M | Sell |
148,100
-3,700
| -2% | -$304K | 0.07% | 257 |
|
|
2024
Q2 | $17.2M | Sell |
151,800
-4,400
| -3% | -$556K | 0.12% | 159 |
|
|
2024
Q1 | $21.7M | Sell |
156,200
-27,300
| -15% | -$3.43M | 0.16% | 142 |
|
|
2023
Q4 | $22.8M | Sell |
183,500
-3,400
| -2% | -$347K | 0.21% | 125 |
|
|
2023
Q3 | $17.4M | Buy |
186,900
+2,200
| +1% | +$248K | 0.17% | 157 |
|
|
2023
Q2 | $23.7M | Sell |
184,700
-9,100
| -5% | -$1.1M | 0.22% | 112 |
|
|
2023
Q1 | $22.5M | Buy |
193,800
+8,400
| +5% | +$940K | 0.23% | 111 |
|
|
2022
Q4 | $21M | Sell |
185,400
-28,800
| -13% | -$3.16M | 0.24% | 109 |
|
|
2022
Q3 | $17.3M | Sell |
214,200
-13,800
| -6% | -$1.17M | 0.18% | 147 |
|
|
2022
Q2 | $17M | Sell |
228,000
-45,600
| -17% | -$4.16M | 0.16% | 168 |
|
|
2022
Q1 | $35M | Sell |
273,600
-19,600
| -7% | -$2.14M | 0.23% | 107 |
|
|
2021
Q4 | $39.4M | Buy |
293,200
+6,800
| +2% | +$977K | 0.23% | 109 |
|
|
2021
Q3 | $39.2M | Buy |
286,400
+4,000
| +1% | +$504K | 0.24% | 111 |
|
|
2021
Q2 | $25.4M | Buy |
+282,400
| New | +$27.1M | 0.2% | 134 |
|
|
2020
Q4 | $29.7M | Buy |
320,800
+2,400
| +0.8% | +$214K | 0.21% | 130 |
|
|
2020
Q3 | $32.8M | Buy |
318,400
+6,000
| +2% | +$627K | 0.26% | 103 |
|
|
2020
Q2 | $31.7M | Buy |
312,400
+2,400
| +0.8% | +$215K | 0.27% | 103 |
|
|
2020
Q1 | $20.9M | Sell |
310,000
-20,000
| -6% | -$1.24M | 0.23% | 99 |
|
|
2019
Q4 | $18M | Buy |
330,000
+16,000
| +5% | +$759K | 0.15% | 156 |
|
|
2019
Q3 | $11.7M | Buy |
314,000
+126,800
| +68% | +$4.93M | 0.11% | 208 |
|
|
2019
Q2 | $7.01M | Buy |
187,200
+122,400
| +189% | +$3.85M | 0.08% | 264 |
|
|
2019
Q1 | $1.93M | Buy |
64,800
+4,800
| +8% | +$169K | 0.02% | 504 |
|
|
2018
Q4 | $1.57M | Buy |
+60,000
| New | +$1.9M | 0.02% | 500 |
|
|
2017
Q4 | – | Sell |
-55,288
| Closed | -$676K | – | 673 |
|
|
2017
Q3 | $676K | Buy |
55,288
+400
| +0.7% | +$7.07K | 0.02% | 652 |
|
|
2017
Q2 | $1M | Buy |
54,888
+45,872
| +509% | +$847K | 0.03% | 600 |
|
|
2017
Q1 | $179K | Buy |
9,016
+332
| +4% | +$6.48K | 0.03% | 521 |
|
|
2016
Q4 | $123K | Buy |
+8,684
| New | +$154K | 0.03% | 588 |
|
Other funds holding DXCM
MN Services Vermogensbeheer's DXCM Position: Q2 2026 in Review
MN Services Vermogensbeheer reduced its DexCom (DXCM) stake by 27% in Q2 2026, selling an estimated $2.77M and leaving 112,077 shares worth $7.55M. The position accounts for 0.06% of the portfolio, ranked #282.
MN Services Vermogensbeheer first reported a position in DXCM in Q4 2016 and has held it in 34 quarters since. The position peaked at $39.4M in Q4 2021. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- MN Services Vermogensbeheer held 112,077 shares of DexCom worth $7.55M as of Q2 2026.
- MN Services Vermogensbeheer sold 41,600 DexCom shares in Q2 2026, an estimated $2.77M.
- DexCom made up 0.06% of MN Services Vermogensbeheer's portfolio in Q2 2026, its #282 holding.
- MN Services Vermogensbeheer first reported a position in DexCom in Q4 2016 and has held it in 34 quarters since.
- MN Services Vermogensbeheer's DexCom position peaked at $39.4M in Q4 2021.
- 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on MN Services Vermogensbeheer's 13F filing for Q2 2026, filed 31 Jul 2026.